Two Seas Capital »

Esperion Therapeutics Inc Ne shares owned by Two Seas Capital

Quarter-by-quarter ownership of Esperion Therapeutics Inc Ne shares owned by Two Seas Capital from 13F filings

Historical chart of Two Seas Capital investment in Esperion Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics Inc Ne held by Two Seas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics Inc Ne by Two Seas Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $9.4M 17M 0.54

More positions owned by Two Seas Capital

Indivior Ord (INDV)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Arbutus Biopharma (ABUS)
3M Company (MMM)
Meta Platforms Cl A (META)
Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
Esperion Therapeutics (ESPR)
Sonos (SONO)
Odyssey Marine Expl Com New (OMEX)
Hertz Global Hldgs Com New (HTZ)
Arcutis Biotherapeutics (ARQT)
Hertz Global Hldgs *w Exp 06/30/205 (HTZWW)

View all positions for Two Seas Capital

Top funds holding Esperion Therapeutics Inc Ne

PenderFund Capital Management
Pentwater Capital Management
Davidson Kempner Capital Management
Highbridge Capital Management
Tenor Capital Management
Whitebox Advisors
Readystate Asset Management
Whitefort Capital Management
Point72 Asset Management
Capstone Investment Advisors
HN Saltoro Capital
Ingalls & Snyder
Context Capital Management

View all funds holding Esperion Therapeutics Inc Ne